Specifically, IL-17 signaling, the only pathway suppressed by baicalein (with a z-score = 2), is an important pathological trigger in many chronic inflammatory neurological diseases, including ischemic brain injury and Alzheimer’s disease (45, 46). Here, IL17A is linked to early-onset autosomal dominant Alzheimer disease.